CIK 0001583648
- Non-accelerated filer
- Smaller reporting company
PALVELLA THERAPEUTICS, INC.
Sign in to watch- Ticker
- PVLA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 300784346
- Phone
- +1 484-253-1461
- Business address
- 353 W. LANCASTER AVENUE, SUITE 200, WAYNE, PA, 19087
- Former names
- PIERIS PHARMACEUTICALS, INC., Marika Inc.
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 445 shares at $112.30 ($49,974)
- 4 Planned sale Chief Operating Officer sold 4,302 shares at an average $117.99 ($507,611)
- 4 Open-market buy Director bought 4,000 shares at $125.00 ($500,000)
- 4 Open-market buy Director bought 2,400 shares at $125.00 ($300,000)
- 4 Planned sale Chief Operating Officer sold 4,302 shares at an average $79.40 ($341,564)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale Chief Operating Officer sold 4,302 shares at an average $97.63 ($419,983)
- 4 Planned sale Chief Operating Officer sold 4,302 shares at $96.47 ($415,023)
- 4 Planned sale Chief Operating Officer sold 4,302 shares at an average $86.23 ($370,965)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 2 of 13 · 252 filings